ITP
TECH icon

Iron Triangle Partners’s Bio-Techne TECH Stock Holding History

Iron Triangle Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$27.5M Buy
+467,409
New +$28.4M 3.14% 17
2025
Q2 		– Sell
-250,000
Closed -$14.7M – 35
2025
Q1 		$14.7M Buy
+250,000
New +$16.9M 2.31% 24

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Iron Triangle Partners's TECH Position: Q4 2025 in Review

Iron Triangle Partners opened a new position in Bio-Techne (TECH) in Q4 2025: 467,409 shares worth $27.5M. The stake represents 3.14% of the portfolio and ranks #17 among its holdings. This is a return to the name: Iron Triangle Partners previously reported a position in TECH as recently as Q1 2025.

Iron Triangle Partners first reported a position in TECH in Q1 2025 and has held it in 2 quarters since. 584 funds tracked by Wall St. Rank hold TECH as of Q4 2025.

  • Iron Triangle Partners held 467,409 shares of Bio-Techne worth $27.5M as of Q4 2025.
  • Bio-Techne was a new Iron Triangle Partners position in Q4 2025.
  • Bio-Techne made up 3.14% of Iron Triangle Partners's portfolio in Q4 2025, its #17 holding.
  • Iron Triangle Partners first reported a position in Bio-Techne in Q1 2025 and has held it in 2 quarters since.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2025.

Based on Iron Triangle Partners's 13F filing for Q4 2025, filed 17 Feb 2026.